Actively Recruiting
Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease
Led by University Hospital, Strasbourg, France · Updated on 2025-08-03
70
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
De Quervain disease is characterized by an adductor pollicis longus and extensor pollicis brevis tendons inflammation as thys pass beneath the extensor retinaculum at the radial styloid. This pathology is recognized as a musculoskeletal disorder of the upper limb triggering functional deficits resulting to possible modifications in the professional activity, sources of absenteeism, thus constituting an economic cost for society. At the etiological level, this pathology also affects young mothers (it's called "mother's wrist" or mommy thumb"), mobile phone users ("textonite", "Blackberryte") or video game players ("Nintendoite"). Currently, the treatment is mainly conservative by splint and anti-inflammatory gel and/or corticosteroid infiltration. Howewer, these therapies have undesirable effects. The interest of this study is therefore to propose another therapy based on aromatherapy gel.
CONDITIONS
Official Title
Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patient aged 18 to 75
- Patient with unilateral De Quervain's tenosynovitis
- Patient cared for in the Hand Surgery, Emergency, or Rheumatology Departments of Strasbourg University Hospitals
- Patient informed of prior medical examination results
- Signed informed consent by the patient
- Patient affiliated with a health insurance social protection scheme or beneficiary
- For women of childbearing potential, negative urine pregnancy test at inclusion and use of effective contraception throughout the study
You will not qualify if you...
- Pregnant or breastfeeding patient
- Allergy to components of the gel with essential oils, Diclofenac, NSAIDs, or excipients
- Treatment with oral non-steroidal anti-inflammatory drugs
- Ongoing treatment with another ointment at the radial wrist treatment site
- Damaged skin at the treatment site, including oozing dermatosis, eczema, infected lesion, burn, or wound
- Atopic skin disease
- Epilepsy or history of epilepsy
- History of homolateral De Quervain's tenosynovitis or corticosteroid infiltrations within 6 months on the same side
- Associated tendinopathies in the elbow or forearm
- Inability to understand information due to emergency situation, cognitive difficulties, or agitation
- Under legal protection, guardianship, or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service SOS Main
Strasbourg, France, 67000
Actively Recruiting
Research Team
M
Marie SCHWEBEL
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here